Home / Drug shortages / Gadoterate Meglumine Injection

Gadoterate Meglumine Injection — FDA Drug Shortage

To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.

The FDA lists a drug shortage record for Gadoterate Meglumine Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on 06/30/2026.

Shortage Details

Status
To Be Discontinued
Company
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Package NDC
65219-084-15
Dosage Form
Injection
Presentation
Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)
Initial Posting
06/30/2026
Revised Date

FDA data resources